We are pleased to advise that Atenolol-AFT (atenolol 50 mg/10 mL) oral liquid 300 mL is now back in stock in both Australia and New Zealand.
Atenolol-AFT – NOW AVAILABLE
Similar articles
Impressive clinical trial results for Maxigesic
AFT Pharmaceuticals has now concluded a pivotal clinical study of 408 patients in the US and NZ. The study will form the basis of AFT’s first filing with the United States Food and Drug Administration for its flagship analgesic Maxigesic
Read more
AFT Group Sales Growth continues at +40%
Growth of 40% per annum continues for AFT Pharmaceuticals in the Australasian market (Australia and NZ) with sales for this year due to break $22 million per annum.
Read more
Maxigesic® Oral Liquid gets first regulatory approval
Maxigesic Oral Liquid – a non-opioid analgesic developed for children – achieves first approval in Europe to set up the first global launch and a pathway for further registrations and launches.
Read more